Citations for
1AGL, GSD3
Distinct mutations in the glycogen debranching enzyme found in glycogen storage disease type III lead to impairment in diverse cellular functions.
Cheng A, Zhang M, Okubo M, Omichi K, Saltiel AR.
Hum Mol Genet 18(11):2045-52. Epub 2009 Mar 19. 2009
2AGL, GSD3
Molecular features of 23 patients with glycogen storage disease type III in Turkey: a novel mutation p.R1147G associated with isolated glucosidase deficiency, along with 9 AGL mutations.
Aoyama Y, Ozer I, Demirkol M, Ebara T, Murase T, Podskarbi T, Shin YS, Gokcay G, Okubo M.
J Hum Genet 54(11):681-6. Epub 2009 Oct 16.PMID: 19834502 2009
3AGL, GSD3
Clinicopathological analysis of the homozygous p.W1327X AGL mutation in glycogen storage disease type 3.
Schoser B, Gläser D, Müller-Höcker J.
Am J Med Genet A 146A(22):2911-5. 2008
4AGL, GSD3
Molecular analysis of the AGL gene: heterogeneity of mutations in patients with glycogen storage disease type III from Germany, Canada, Afghanistan, Iran, and Turkey.
Endo Y, Horinishi A, Vorgerd M, Aoyama Y, Ebara T, Murase T, Odawara M, Podskarbi T, Shin YS, Okubo M.
J Hum Genet 51(11):958-63. Epub 2006 Sep 19. 2006
5AGL, GSD3
Glycogen debranching enzyme association with beta-subunit regulates AMP-activated protein kinase activity.
Sakoda H, Fujishiro M, Fujio J, Shojima N, Ogihara T, Kushiyama A, Fukushima Y, Anai M, Ono H, Kikuchi M, Horike N, Viana AY, Uchijima Y, Kurihara H, Asano T.
Am J Physiol Endocrinol Metab 289(3):E474-81. Epub 2005 May 10. 2005
6AGL
Clinical and genetic variability of glycogen storage disease type IIIa: seven novel AGL gene mutations in the Mediterranean area.
Lucchiari S, Fogh I, Prelle A, Parini R, Bresolin N, Melis D, Fiori L, Scarlato G, Comi GP.
Am J Med Genet 109(3):183-90. 2002
7AGL, GSD3
Mutational and haplotype analysis of AGL in patients with glycogen storage disease type III.
Horinishi A, Okubo M, Tang NL, Hui J, To KF, Mabuchi T, Okada T, Mabuchi H, Murase T.
J Hum Genet 47(2):55-9. 2002
8AGL, GSD3
Heterogeneous mutations in the glycogen-debranching enzyme gene are responsible for glycogen storage disease type IIIa in Japan.
Okubo M, Horinishi A, Takeuchi M, Suzuki Y, Sakura N, Hasegawa Y, Igarashi T, Goto K, Tahara H, Uchimoto S, Omichi K, Kanno H, Hayasaka K, Murase T.
Hum Genet 106:108-115 2000
9AGL, GSD3
Compound heterozygous patient with glycogen storage disease type III: identification of two novel AGL mutations, a donor splice site mutation of Chinese origin and a 1-bp deletion of Japanese origin.
Okubo M, Horinishi A, Suzuki Y, Murase T, Hayasaka K.
Am J Med Genet 93(3):211-4. 2000
10AGL
Isolation and nucleotide sequence of human liver glycogen debranching enzyme mRNA: identification of multiple tissue-specific isoforms.
Bao Y, Yang BZ, Dawson TL Jr, Chen YT.
Gene 197(1-2):389-98. 1997
11AGL, GSD3
A single-base deletion in the 3'-coding region of glycogen-debranching enzyme is prevalent in glycogen storage disease type IIIA in a population of North African Jewish patients.
Parvari R, Moses S, Shen J, Hershkovitz E, Lerner A, Chen YT.
Eur J Hum Genet 5(5):266-70. 1997
12AGL
Human glycogen debranching enzyme gene (AGL) : complete structural organization and characterization of the 5' flanking region.
Bao Y, et al.
Genomics 38 : 155-165. 1996
13AGL
Molecular cloning and nucleotide sequence of cDNA encoding human muscle glycogen debranching enzyme.
Yang BZ, et al.
J Biol Chem 267 : 9294-9299. 1992